Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Alaunos Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 46 | 50 | +4 |
| Shares | 2.35M | 2.41M | +61.6K (+2.6%) |
| Value | $4.23M | $1.69M | −$2.54M (−60.1%) |
New holders (11)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sanctuary Advisors, LLC | 12,299 | $16.2K | 0.00% |
| Citadel Advisors LLC | 16,905 | $11.8K | 0.00% |
| PFG Investments, LLC | 16,166 | $11.3K | 0.00% |
| Two Sigma Securities, LLC | 10,233 | $7.15K | 0.00% |
| HRT Financial LP | 10,480 | $7.00K | 0.00% |
| Asset Dedication, LLC | 550 | $385 | 0.00% |
| Redwood Wealth Management Group, LLC | 200 | $140 | 0.00% |
| Northwestern Mutual Wealth Management Co | 166 | $116 | 0.00% |
| Family Firm, Inc. | 7 | $5 | 0.00% |
| Trust Co of Vermont | 6 | $4 | 0.00% |
| Ashton Thomas Private Wealth, LLC | 5 | $3 | 0.00% |
Sold out (7)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Virtu Financial LLC | 15,440 | $28.0K |
| Magnolia Capital Advisors LLC | 24,695 | $27.7K |
| NBC Securities, Inc. | 200 | $1.00K |
| Harbour Investments, Inc. | 466 | $843 |
| Sound Income Strategies, LLC | 48 | $87 |
| Central Trust Co | 10 | $19 |
| Truvestments Capital LLC | 1 | $2 |